2024
DOI: 10.1007/s11427-023-2554-y
|View full text |Cite
|
Sign up to set email alerts
|

Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials

Jinliang Wang,
Wenyong Zhou,
Yu Xu
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 75 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?